screening guidelines

Research in Review

Women Treated for Precursor of Breast Cancer Live Longer Than Other Women

01/27/2017

JCP Editors

Women aged 50 years or older who have been treated for ductal carcinoma in situ (DCIS) are likely to live longer than women in the general population, according to a presentation at the European Cancer Congress...

Women...

01/27/2017

Journal of Clinical Pathways

Research in Review

Decreased PSA Screening Leads to Higher Rates of Metastatic Prostate Cancer in Older Men

01/03/2017

JCP Editors

Increase in metastatic prostate cancer in older men has a definitive correlation with changes in prostate cancer screening guidelines recommending against prostate-specific antigen (PSA) testing, according to...

...

01/03/2017

Journal of Clinical Pathways

Research in Review

Depression May Cause Decreased Response to Chemotherapy

12/21/2016

JCP Editors

Patients with cancer who are suffering from depression may be less responsive to cancer drugs and less tolerant of their side-effects, a new study shows. ----- Related Content Psychedelic drug psilocybin relieves...

...

12/21/2016

Journal of Clinical Pathways

Research in Review

A Road Map for Using Biomarkers in Clinical Practice

12/16/2016

JCP Editors

New consensus guidelines provide a "road map" for the appropriate implementation of imaging biomarkers in clinical practice. ----- Related Content Biomarkers Predict Cetuximab Performance in Metastatic Colorectal...

New...

12/16/2016

Journal of Clinical Pathways

Research in Review

Clinical Pathway Improves Screening and Treatment for Osteoporosis

10/12/2016

JCP Editors

Despite the high frequency of osteoporosis, it is still underdiagnosed and undertreated in many health care settings. However, a group of Belgium researchers may have developed a clinical pathway capable of improving...

...

10/12/2016

Journal of Clinical Pathways

Research in Review

ALK Inhibitor Treatment Response Better Predicted With Combo Genetic Screening

09/26/2016

JCP Editors

Combining fluorescence in situ hybridization (FISH) analysis and immunohistochemistry (IHC) assays may help to identify rare anaplastic lymphoma kinase (ALK) mutations in patients with non-small cell lung...

...

09/26/2016

Journal of Clinical Pathways

Research in Review

Scan-associated Distress Common and Problematic Among Patients With NSCLC

08/25/2016

JCP Editors

Scan-associated distress, a common problem among patients with non-small cell lung cancer (NSCLC), may negatively affect quality of life, according to a study published in the journal Lung Cancer. Commonly referred...

...

08/25/2016

Journal of Clinical Pathways

Research in Review

Better Survival With Lung Cancer Detected Through Scheduled Screening

08/23/2016

JCP Editors

Lung cancers detected after initial screenings have better survival than patients who have negative results at baseline and later test positive, according to a study published in Plos One. For their study, the...

Lung...

08/23/2016

Journal of Clinical Pathways

Corrigendum

Corrigendum: Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer`s Treatments?

08/02/2016

Rick Lifsitz, MBA

Larry Blandford, PharmD—Column Editor

In the June 2016 article, “Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer’s Treatments?"1 the author and column editor would like to clarify several points....

In the...

08/02/2016

Journal of Clinical Pathways

Research in Review

Better Screening May Eliminate the Need for Lung Cancer Surgery in Some Patients

07/22/2016

JCP Editors

A new, large-scale study has lent support to the recommendation that nonsolid nodules identified by CT (computed tomography) scans can be managed with annual screening rather than with invasive biopsies or...

A new,...

07/22/2016

Journal of Clinical Pathways